Contemporary lung transplantation: the UCLA experience

Area of Science:

• Pulmonary Medicine
• Transplant Surgery
• Immunology

Background:

• Lung transplantation is an established therapy for end-stage lung disease, with survival rates improving over the last decade.
• Advances include enhanced donor management, improved surgical care, and refined immunosuppression protocols.
• Despite progress, significant challenges persist, impacting long-term patient outcomes.

Purpose of the Study:

• To review the advancements in lung transplantation over the past decade.
• To identify the persistent challenges facing the field.
• To discuss potential strategies for overcoming these obstacles and improving patient survival.

Main Methods:

• Review of current literature and clinical practices in lung transplantation.
• Analysis of factors contributing to improved survival rates.
• Identification and discussion of major challenges: donor shortage, acute rejection, and chronic allograft dysfunction.

Main Results:

• Improved survival attributed to better donor management, allocation systems, surgical care, and immunosuppression.
• Donor lung shortage persists despite the use of "non-standard" lungs.
• Acute rejection remains a significant cause of morbidity and a risk factor for chronic allograft dysfunction.

Conclusions:

• Chronic allograft dysfunction is the primary cause of late mortality after lung transplantation.
• Addressing donor shortages through expanded criteria and considering lungs after cardiac death is crucial.
• Developing targeted immunosuppression and diagnostic tools, alongside managing factors like GERD and infections, is vital for improving long-term lung transplant success.